b'<?xml version="1.0" ?>\n<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">\n<PubmedArticleSet>\n<PubmedArticle>\n    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">\n        <PMID Version="1">29937558</PMID>\n        <DateRevised>\n            <Year>2019</Year>\n            <Month>11</Month>\n            <Day>20</Day>\n        </DateRevised>\n        <Article PubModel="Print">\n            <Journal>\n                <ISSN IssnType="Electronic">1998-3611</ISSN>\n                <JournalIssue CitedMedium="Internet">\n                    <Volume>63</Volume>\n                    <Issue>3</Issue>\n                    <PubDate>\n                        <MedlineDate>2018 May-Jun</MedlineDate>\n                    </PubDate>\n                </JournalIssue>\n                <Title>Indian journal of dermatology</Title>\n                <ISOAbbreviation>Indian J Dermatol</ISOAbbreviation>\n            </Journal>\n            <ArticleTitle>Polymorphism of FAS and FAS Ligand Genes in Alopecia Areata: A Case-control Study in Egyptian Population.</ArticleTitle>\n            <Pagination>\n                <MedlinePgn>220-226</MedlinePgn>\n            </Pagination>\n            <ELocationID EIdType="doi" ValidYN="Y">10.4103/ijd.IJD_286_17</ELocationID>\n            <Abstract>\n                <AbstractText Label="Background" NlmCategory="UNASSIGNED">Alopecia areata (AA) is a common dermatologic disease with suspected autoimmune etiology. Tumor necrosis factor superfamily member 6 or CD95 (FAS) and FAS ligand (FASL) are proapoptotic proteins. The relationship between apoptosis and autoimmunity is well recognized. Inflammatory T cells in AA are cytotoxic and possess FAS/FASL antigens.</AbstractText>\n                <AbstractText Label="Aim" NlmCategory="UNASSIGNED">This study aims to investigate the association between FAS-670 A/G and FASL-124 A/G gene polymorphisms and AA to clarify if these polymorphisms influence disease occurrence or increase disease risk.</AbstractText>\n                <AbstractText Label="Materials and Methods" NlmCategory="UNASSIGNED">A case-control study was conducted on sixty patients with AA, and 40 age- and sex-matched healthy subjects, as a control group. Disease severity was assessed by severity of alopecia tool (SALT) Score. FAS 670A/G and FASL 124A/G gene polymorphisms were investigated by the restriction fragment length polymorphism polymerase chain reaction.</AbstractText>\n                <AbstractText Label="Results" NlmCategory="UNASSIGNED">For FAS gene, G/G genotype was significantly higher in cases than in control group with odds ratio 5.1. G allele was more prevalent among patient group with odds ratio 1.75. For FASL gene, A/G genotype was significantly higher in cases than in control group with odds ratio 4.53. G allele was more prevalent among patient group with odds ratio 1.88. GG genotype of FAS was significantly associated with longer disease duration (<i>P</i> =0.001), recurrent attacks (<i>P</i> =0.01), higher SALT score (<i>P</i> =0.009), alopecia universalis (<i>P</i> =0.002), and severe disease (<i>P</i> =0.006).</AbstractText>\n                <AbstractText Label="Conclusion" NlmCategory="UNASSIGNED">FAS and FASL gene polymorphisms are associated with AA. Further large-scale studies on different ethnicities are required for more clarification of their role in disease development. Therapeutic modalities based on their inhibition could be promising in the treatment of a common disease like AA.</AbstractText>\n            </Abstract>\n            <AuthorList CompleteYN="Y">\n                <Author ValidYN="Y">\n                    <LastName>Seleit</LastName>\n                    <ForeName>Iman</ForeName>\n                    <Initials>I</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Dermatology, Andrology and STDs, Faculty of Medicine, Menoufiya University, Egypt.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Bakry</LastName>\n                    <ForeName>Ola Ahmed</ForeName>\n                    <Initials>OA</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Dermatology, Andrology and STDs, Faculty of Medicine, Menoufiya University, Egypt.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Gayed</LastName>\n                    <ForeName>Eman Abd El</ForeName>\n                    <Initials>EAE</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Medical Biochemistry, Faculty of Medicine, Menoufiya University, Egypt.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Gawad</LastName>\n                    <ForeName>Abd El D</ForeName>\n                    <Initials>AED</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Dermatology, Andrology and STDs, Faculty of Medicine, Menoufiya University, Egypt.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n            </AuthorList>\n            <Language>eng</Language>\n            <PublicationTypeList>\n                <PublicationType UI="D016428">Journal Article</PublicationType>\n            </PublicationTypeList>\n        </Article>\n        <MedlineJournalInfo>\n            <Country>India</Country>\n            <MedlineTA>Indian J Dermatol</MedlineTA>\n            <NlmUniqueID>0370750</NlmUniqueID>\n            <ISSNLinking>0019-5154</ISSNLinking>\n        </MedlineJournalInfo>\n        <KeywordList Owner="NOTNLM">\n            <Keyword MajorTopicYN="N">Alopecia areata</Keyword>\n            <Keyword MajorTopicYN="N">FAS</Keyword>\n            <Keyword MajorTopicYN="N">FAS ligand</Keyword>\n            <Keyword MajorTopicYN="N">apoptosis</Keyword>\n            <Keyword MajorTopicYN="N">autoimmunity</Keyword>\n            <Keyword MajorTopicYN="N">polymorphism</Keyword>\n        </KeywordList>\n        <CoiStatement>There are no conflicts of interest. What is new? This is the first study to report an association between FAS-670 A/G and FASL-124 A/G gene polymorphism and AA in Egyptian population.GG genotype of FAS is associated with longer disease duration, recurrent attacks, higher SALT score, alopecia universalis, and severe disease.</CoiStatement>\n    </MedlineCitation>\n    <PubmedData>\n        <History>\n            <PubMedPubDate PubStatus="entrez">\n                <Year>2018</Year>\n                <Month>6</Month>\n                <Day>26</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="pubmed">\n                <Year>2018</Year>\n                <Month>6</Month>\n                <Day>26</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="medline">\n                <Year>2018</Year>\n                <Month>6</Month>\n                <Day>26</Day>\n                <Hour>6</Hour>\n                <Minute>1</Minute>\n            </PubMedPubDate>\n        </History>\n        <PublicationStatus>ppublish</PublicationStatus>\n        <ArticleIdList>\n            <ArticleId IdType="pubmed">29937558</ArticleId>\n            <ArticleId IdType="doi">10.4103/ijd.IJD_286_17</ArticleId>\n            <ArticleId IdType="pii">IJD-63-220</ArticleId>\n            <ArticleId IdType="pmc">PMC5996631</ArticleId>\n        </ArticleIdList>\n        <ReferenceList>\n            <Reference>\n                <Citation>J Investig Dermatol Symp Proc. 2003 Jun;8(1):104-8</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">12895005</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Indian J Dermatol. 2008;53(2):70-4</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">19881991</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Clin Invest. 2007 Aug;117(8):2019-27</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">17671634</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Clin Cancer Res. 2002 Aug;8(8):2488-98</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">12171874</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Clin Immunol. 2001 Jun;99(3):340-6</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">11358429</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Cell Death Differ. 2003 Jan;10(1):36-44</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">12655294</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Blood. 1999 May 15;93(10):3309-16</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">10233883</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Nat Rev Immunol. 2003 Sep;3(9):745-56</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">12949498</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Am Acad Dermatol. 2010 Feb;62(2):177-88, quiz 189-90</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">20115945</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Mol Immunol. 1997 Jun;34(8-9):577-82</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">9393960</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Biol Chem. 2014 Dec;395(12):1401-16</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">25153377</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Invest Ophthalmol Vis Sci. 1999 Sep;40(10):2199-212</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">10476784</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Arch Dermatol Res. 2003 Mar;294(12):536-43</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">12624779</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Br J Dermatol. 2010 Aug;163(2):340-4</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">20394629</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Trends Immunol. 2005 Jan;26(1):32-40</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">15629407</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>World J Gastroenterol. 2004 Mar 1;10(5):717-20</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">14991945</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Invest Dermatol. 2008 May;128(5):1196-206</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">18160967</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Curr Pharm Des. 2001 Feb;7(3):213-30</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">11311114</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Arch Dermatol. 2003 Dec;139(12):1555-9</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">14676070</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Am Acad Dermatol. 2004 Sep;51(3):440-7</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">15337988</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Life Sci. 2003 May 9;72(25):2803-24</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">12697265</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Autoimmun. 2008 Nov;31(3):257-62</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">18513925</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Cell Physiol. 1999 Oct;181(1):45-54</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">10457352</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Biol Chem. 2004 Aug 27;279(35):36242-9</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">15173177</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Carcinogenesis. 2010 Dec;31(12):2165-71</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">20889682</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Int Immunol. 1994 Oct;6(10):1567-74</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">7826947</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Biol Chem. 1997 Jan 10;272(2):1226-30</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">8995425</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Mol Ther. 2000 Oct;2(4):348-58</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">11020350</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Int J Dermatol. 2000 Aug;39(8):589-92</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">10971726</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Curr Opin Cell Biol. 1994 Apr;6(2):253-9</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">8024817</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Neuropathol Exp Neurol. 2000 Apr;59(4):280-6</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">10759183</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>N Engl J Med. 2009 Oct 15;361(16):1570-83</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">19828534</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Arch Dermatol Res. 2013 Dec;305(10):909-15</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">23591741</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Oncogene. 2000 Jan 13;19(2):265-72</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">10645005</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Invest Dermatol. 2000 Jan;114(1):112-6</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">10620125</ArticleId>\n                </ArticleIdList>\n            </Reference>\n        </ReferenceList>\n    </PubmedData>\n</PubmedArticle>\n\n</PubmedArticleSet>'